ATP7B and Wilson disease: There are ongoing clinical trials of AAV-mediated gene transfer of ATP7B in humans, in which Wilson disease patients receive a single, peripheral intravenous infusion of UX701 or placebo, as outlined in detail by the US National Institute of Health (NIH) on their website, clinicaltrials.gov.